These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 21978287

  • 1. Vitamin D levels and markers of arterial dysfunction in HIV.
    Shikuma CM, Seto T, Liang CY, Bennett K, DeGruttola V, Gerschenson M, Stein JH, Budoff M, Hodis HN, Delaney JA, Ogata-Arakaki D, Pramyothin P, Chow D.
    AIDS Res Hum Retroviruses; 2012 Aug; 28(8):793-7. PubMed ID: 21978287
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Vitamin D Levels and Markers of Inflammation and Metabolism in HIV-Infected Individuals on Suppressive Antiretroviral Therapy.
    Hoffman RM, Lake JE, Wilhalme HM, Tseng CH, Currier JS.
    AIDS Res Hum Retroviruses; 2016 Mar; 32(3):247-54. PubMed ID: 26569649
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Plasma monocyte chemoattractant protein-1 and tumor necrosis factor-α levels predict the presence of coronary artery calcium in HIV-infected individuals independent of traditional cardiovascular risk factors.
    Shikuma CM, Barbour JD, Ndhlovu LC, Keating SM, Norris PJ, Budoff M, Parikh N, Seto T, Gangcuangco LM, Ogata-Arakaki D, Chow D.
    AIDS Res Hum Retroviruses; 2014 Feb; 30(2):142-6. PubMed ID: 23984974
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Risk Factors of Hypovitaminosis D in HIV-Infected Patients on Suppressive Antiretroviral Therapy.
    Mikuła T, Sapuła M, Suchacz MM, Kozłowska J, Krankowska D, Stańczak W, Wiercińska-Drapało A.
    AIDS Res Hum Retroviruses; 2020 Aug; 36(8):676-680. PubMed ID: 32408752
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Ultrasonographic measures of cardiovascular disease risk in antiretroviral treatment-naive individuals with HIV infection.
    Stein JH, Brown TT, Ribaudo HJ, Chen Y, Yan M, Lauer-Brodell E, McComsey GA, Dubé MP, Murphy RL, Hodis HN, Currier JS.
    AIDS; 2013 Mar 27; 27(6):929-937. PubMed ID: 23196938
    [Abstract] [Full Text] [Related]

  • 16. Vitamin D and progression of carotid intima-media thickness in HIV-positive Canadians.
    Huff H, Merchant AT, Lonn E, Pullenayegum E, Smaill F, Smieja M.
    HIV Med; 2018 Feb 27; 19(2):143-151. PubMed ID: 29110385
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Risk of cardiovascular disease in a cohort of HIV-infected adults: a study using carotid intima-media thickness and coronary artery calcium score.
    Mangili A, Gerrior J, Tang AM, O'Leary DH, Polak JK, Schaefer EJ, Gorbach SL, Wanke CA.
    Clin Infect Dis; 2006 Dec 01; 43(11):1482-9. PubMed ID: 17083026
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.